ADAP Crosses Above Average Analyst Target Wednesday, June 17, 7:33 AM ET, by Market News Video Staff In recent trading, shares of Adaptimmune Therapeutics PLC (ADAP) have crossed above the average analyst ...
ADAP Crosses Above Average Analyst Target Thursday, September 17, 8:13 AM ET, by Market News Video Staff In recent trading, shares of Adaptimmune Therapeutics PLC (ADAP) have crossed above the average analyst ...
Investors in Adaptimmune Therapeutics PLC (NASDAQ:ADAP) saw new options become available this week, for the January 2021 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ADAP options chain for the new January 2021 contracts and identified the following call contract of particular interest.
The call contract at the $5.00 strike price has a current bid of 40 cents. If an investor was to purchase shares of ADAP stock at the current price level of $4.50/share, and then sell-to-open that call contract as a "covered call," they are committing to sell the stock at $5.00. Considering the call seller will also collect the premium, that would drive a total return (excluding dividends, if any) of 20.00% if the stock gets called away at the January 2021 expiration (before broker commissions). Of course, a lot of upside could potentially be left on the table if ADAP shares really soar, which is why looking at the trailing twelve month trading history for Adaptimmune Therapeutics PLC, as well as studying the business fundamentals becomes important. Below is a chart showing ADAP's trailing twelve month trading history, with the $5.00 strike highlighted in red:
Considering the fact that the $5.00 strike represents an approximate 11% premium to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the covered call contract would expire worthless, in which case the investor would keep both their shares of stock and the premium collected. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 44%. On our website under the contract detail page for this contract, Stock Options Channel will track those odds over time to see how they change and publish a chart of those numbers (the trading history of the option contract will also be charted). Should the covered call contract expire worthless, the premium would represent a 8.89% boost of extra return to the investor, or 63.62% annualized, which we refer to as the YieldBoost.
The implied volatility in the call contract example above is 170%.
Meanwhile, we calculate the actual trailing twelve month volatility (considering the last 252 trading day closing values as well as today's price of $4.50) to be 168%. For more put and call options contract ideas worth looking at, visit StockOptionsChannel.com.
This Article's Word Cloud:ADAPAdaptimmuneArialBelowCallsChannelConsideringJanuaryOptionsStockTherapeuticsYieldBoostalsocallchartcontractcoveredcurrentexpirationexpirefillColorgreekshistoryimpliedinvestorleftlookingmonthoddsoptionspremiumpricereturnsellsharesstockstrikethattheythisthosetradingtrailingtwelvevolatilitywellwhichwillworthlesswould
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.